TreeWAS – Variant ID: rs12719264

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C34.1 Upper lobe, bronchus or lung	0.101	0.899	0.000
C34 Malignant neoplasm of bronchus and lung	0.081	0.919	0.000
C34.9 Bronchus or lung, unspecified	0.078	0.922	0.000
C34.0 Main bronchus	0.066	0.934	0.000
C34.2 Middle lobe, bronchus or lung	0.064	0.936	0.000
C34.8 Overlapping lesion of bronchus and lung	0.059	0.941	0.000
R01.1 Cardiac murmur, unspecified	0.000	0.950	0.050
Z80.8 Family history of malignant neoplasm of other organs or systems	0.037	0.963	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.033	0.966	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.029	0.971	0.000
C38.4 Pleura	0.025	0.974	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.025	0.975	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.024	0.976	0.000
C31 Malignant neoplasm of accessory sinuses	0.024	0.976	0.000
C33 Malignant neoplasm of trachea	0.024	0.976	0.000
C38.3 Mediastinum, part unspecified	0.023	0.976	0.000
C37 Malignant neoplasm of thymus	0.023	0.977	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.021	0.979	0.000
C38.2 Posterior mediastinum	0.021	0.979	0.000
C38.1 Anterior mediastinum	0.021	0.979	0.000
C38.0 Heart	0.021	0.979	0.000
Z80.4 Family history of malignant neoplasm of genital organs	0.020	0.980	0.000
Z80 Family history of malignant neoplasm	0.019	0.981	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.019	0.981	0.000
Z80.6 Family history of leukaemia	0.018	0.982	0.000
C30.0 Nasal cavity	0.018	0.982	0.000
C30.1 Middle ear	0.018	0.982	0.000
C31.9 Accessory sinus, unspecified	0.017	0.982	0.000
C31.8 Overlapping lesion of accessory sinuses	0.017	0.982	0.000
C31.3 Sphenoidal sinus	0.017	0.982	0.000
C31.2 Frontal sinus	0.017	0.982	0.000
C31.1 Ethmoidal sinus	0.017	0.982	0.000
C31.0 Maxillary sinus	0.017	0.982	0.000
C39.9 Ill-defined sites within the respiratory system	0.017	0.982	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.017	0.982	0.000
C39.0 Upper respiratory tract, part unspecified	0.017	0.982	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.018	0.982	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.017	0.983	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.017	0.983	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.017	0.983	0.000
R01 Cardiac murmurs and other cardiac sounds	0.000	0.984	0.016
Z80.5 Family history of malignant neoplasm of urinary tract	0.016	0.984	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.015	0.984	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.015	0.985	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.015	0.985	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.015	0.985	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.015	0.985	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.014	0.986	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.014	0.986	0.000
C32 Malignant neoplasm of larynx	0.014	0.986	0.000
Z80.7 Family history of malignant neoplasms of lymphoid, haematopoietic and related tissues	0.014	0.986	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.014	0.986	0.000
C34.3 Lower lobe, bronchus or lung	0.014	0.986	0.000
T42.3 Barbiturates	0.013	0.987	0.000
T43.6 Psychostimulants with abuse potential	0.013	0.987	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.013	0.987	0.000
T42.4 Benzodiazepines	0.013	0.987	0.000
T40.2 Other opioids	0.013	0.987	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.013	0.987	0.000
T43.9 Psychotropic drug, unspecified	0.013	0.987	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.013	0.987	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.013	0.987	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.012	0.987	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.012	0.987	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.012	0.988	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.012	0.988	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.012	0.988	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.012	0.988	0.000
T42.2 Succinimides and oxazolidinediones	0.012	0.988	0.000
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung	0.012	0.988	0.000
T50.8 Diagnostic agents	0.012	0.988	0.000
T59.8 Other specified gases, fumes and vapours	0.012	0.988	0.000
T41.2 Other and unspecified general anaesthetics	0.012	0.988	0.000
T45.0 Antiallergic and antiemetic drugs	0.012	0.988	0.000
B02.9 Zoster without complication	0.012	0.988	0.000
R01.2 Other cardiac sounds	0.000	0.988	0.012
T40.6 Other and unspecified narcotics	0.011	0.988	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.011	0.988	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.011	0.989	0.000
Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs	0.011	0.989	0.000
T47.4 Other laxatives	0.011	0.989	0.000
T47.2 Stimulant laxatives	0.011	0.989	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.011	0.989	0.000
T47.0 Histamine H(2)-receptor antagonists	0.011	0.989	0.000
T36 Poisoning by systemic antibiotics	0.011	0.989	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.989	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.989	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.989	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.989	0.000
T44.0 Anticholinesterase agents	0.011	0.989	0.000
T42.0 Hydantoin derivatives	0.011	0.989	0.000
T59 Toxic effect of other gases, fumes and vapours	0.011	0.989	0.000
T50.7 Analeptics and opioid receptor antagonists	0.011	0.989	0.000
T50.5 Appetite depressants	0.011	0.989	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.011	0.989	0.000
T50.1 Loop [high-ceiling] diuretics	0.011	0.989	0.000
T50.0 Mineralocorticoids and their antagonists	0.011	0.989	0.000
T40.5 Cocaine	0.011	0.989	0.000
B02 Zoster [herpes zoster]	0.011	0.989	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.011	0.989	0.000
T56.8 Other metals	0.011	0.989	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.011	0.989	0.000
T40.8 Lysergide [LSD]	0.011	0.989	0.000
T40.7 Cannabis (derivatives)	0.011	0.989	0.000
T40.3 Methadone	0.011	0.989	0.000
T40.1 Heroin	0.011	0.989	0.000
T40.0 Opium	0.011	0.989	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.011	0.989	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.011	0.989	0.000
T42.1 Iminostilbenes	0.011	0.989	0.000
T38.1 Thyroid hormones and substitutes	0.010	0.989	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.010	0.989	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.010	0.990	0.000
T41.5 Therapeutic gases	0.010	0.990	0.000
T41.4 Anaesthetic, unspecified	0.010	0.990	0.000
T41.3 Local anaesthetics	0.010	0.990	0.000
T41.1 Intravenous anaesthetics	0.010	0.990	0.000
T41.0 Inhaled anaesthetics	0.010	0.990	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.010	0.990	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.990	0.000
T47.7 Emetics	0.010	0.990	0.000
T47.6 Antidiarrhoeal drugs	0.010	0.990	0.000
T47.5 Digestants	0.010	0.990	0.000
T47.3 Saline and osmotic laxatives	0.010	0.990	0.000
C32.8 Overlapping lesion of larynx	0.010	0.990	0.000
C32.3 Laryngeal cartilage	0.010	0.990	0.000
C32.2 Subglottis	0.010	0.990	0.000
B02.2 Zoster with other nervous system involvement	0.010	0.990	0.000
T56 Toxic effect of metals	0.010	0.990	0.000
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.010	0.990	0.000
B08.1 Molluscum contagiosum	0.009	0.991	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.009	0.991	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.009	0.991	0.000
T48.5 Anti-common-cold drugs	0.009	0.991	0.000
T48.4 Expectorants	0.009	0.991	0.000
T48.3 Antitussives	0.009	0.991	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.009	0.991	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.009	0.991	0.000
T48.0 Oxytocic drugs	0.009	0.991	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.009	0.991	0.000
T45.8 Other primarily systemic and haematological agents	0.009	0.991	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.009	0.991	0.000
T45.6 Fibrinolysis-affecting drugs	0.009	0.991	0.000
T45.4 Iron and its compounds	0.009	0.991	0.000
T45.3 Enzymes, not elsewhere classified	0.009	0.991	0.000
Z80.9 Family history of malignant neoplasm, unspecified	0.009	0.991	0.000
R01.0 Benign and innocent cardiac murmurs	0.000	0.991	0.009
T38.9 Other and unspecified hormone antagonists	0.009	0.991	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.009	0.991	0.000
T38.7 Androgens and anabolic congeners	0.009	0.991	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.009	0.991	0.000
T38.5 Other oestrogens and progestogens	0.009	0.991	0.000
T38.4 Oral contraceptives	0.009	0.991	0.000
T38.2 Antithyroid drugs	0.009	0.991	0.000
T38.0 Glucocorticoids and synthetic analogues	0.009	0.991	0.000
S52.00 Fracture of upper end of ulna (closed)	0.000	0.991	0.009
T59.9 Gases, fumes and vapours, unspecified	0.009	0.991	0.000
T49.9 Topical agent, unspecified	0.009	0.991	0.000
T49.8 Other topical agents	0.009	0.991	0.000
T49.7 Dental drugs, topically applied	0.009	0.991	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.009	0.991	0.000
T49.5 Ophthalmological drugs and preparations	0.009	0.991	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.009	0.991	0.000
T49.3 Emollients, demulcents and protectants	0.009	0.991	0.000
T49.2 Local astringents and local detergents	0.009	0.991	0.000
T49.1 Antipruritics	0.009	0.991	0.000
B02.1 Zoster meningitis	0.009	0.991	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.009	0.991	0.000
T37.5 Antiviral drugs	0.009	0.991	0.000
T37.4 Anthelminthics	0.009	0.991	0.000
T37.3 Other antiprotozoal drugs	0.009	0.991	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.009	0.991	0.000
T37.1 Antimycobacterial drugs	0.009	0.991	0.000
T37.0 Sulphonamides	0.009	0.991	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.009	0.991	0.000
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.009	0.991	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.009	0.991	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.009	0.991	0.000
B07 Viral warts	0.009	0.991	0.000
K22.0 Achalasia of cardia	0.009	0.991	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.009	0.991	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.009	0.991	0.000
T40.4 Other synthetic narcotics	0.009	0.991	0.000
T45.2 Vitamins, not elsewhere classified	0.009	0.991	0.000
T36.3 Macrolides	0.009	0.991	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.009	0.991	0.000
T39.4 Antirheumatics, not elsewhere classified	0.008	0.992	0.000
T39.2 Pyrazolone derivatives	0.008	0.992	0.000
T51.0 Ethanol	0.008	0.992	0.000
T51 Toxic effect of alcohol	0.008	0.992	0.000
C32.9 Larynx, unspecified	0.008	0.992	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.008	0.992	0.000
T36.9 Systemic antibiotic, unspecified	0.008	0.992	0.000
T36.8 Other systemic antibiotics	0.008	0.992	0.000
T36.7 Antifungal antibiotics, systemically used	0.008	0.992	0.000
T36.6 Rifamycins	0.008	0.992	0.000
T36.5 Aminoglycosides	0.008	0.992	0.000
T36.4 Tetracyclines	0.008	0.992	0.000
T36.2 Chloramphenicol group	0.008	0.992	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.008	0.992	0.000
C32.1 Supraglottis	0.008	0.992	0.000
T59.7 Carbon dioxide	0.008	0.992	0.000
T59.6 Hydrogen sulphide	0.008	0.992	0.000
T59.5 Fluorine gas and hydrogen fluoride	0.008	0.992	0.000
T59.4 Chlorine gas	0.008	0.992	0.000
T59.3 Lachrymogenic gas	0.008	0.992	0.000
T59.2 Formaldehyde	0.008	0.992	0.000
T59.1 Sulphur dioxide	0.008	0.992	0.000
T59.0 Nitrogen oxides	0.008	0.992	0.000
B02.7 Disseminated zoster	0.008	0.992	0.000
B02.0 Zoster encephalitis	0.008	0.992	0.000
C32.0 Glottis	0.008	0.992	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.008	0.992	0.000
T54 Toxic effect of corrosive substances	0.008	0.992	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.008	0.992	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.008	0.992	0.000
T46.7 Peripheral vasodilators	0.008	0.992	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.008	0.992	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.008	0.992	0.000
T46.1 Calcium-channel blockers	0.008	0.992	0.000
T58 Toxic effect of carbon monoxide	0.008	0.992	0.000
T56.9 Metal, unspecified	0.007	0.992	0.000
T56.7 Beryllium and its compounds	0.007	0.992	0.000
T56.6 Tin and its compounds	0.007	0.992	0.000
T56.5 Zinc and its compounds	0.007	0.992	0.000
T56.4 Copper and its compounds	0.007	0.992	0.000
T56.3 Cadmium and its compounds	0.007	0.992	0.000
T56.2 Chromium and its compounds	0.007	0.992	0.000
T56.1 Mercury and its compounds	0.007	0.992	0.000
T56.0 Lead and its compounds	0.007	0.992	0.000
B02.8 Zoster with other complications	0.007	0.993	0.000
T62 Toxic effect of other noxious substances eaten as food	0.007	0.993	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.007	0.993	0.000
T60 Toxic effect of pesticides	0.007	0.993	0.000
T57 Toxic effect of other inorganic substances	0.007	0.993	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.007	0.993	0.000
T52 Toxic effect of organic solvents	0.007	0.993	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.007	0.993	0.000
T55 Toxic effect of soaps and detergents	0.007	0.993	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.007	0.993	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.007	0.993	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
T54.9 Corrosive substance, unspecified	0.007	0.993	0.000
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.007	0.993	0.000
B08.5 Enteroviral vesicular pharyngitis	0.007	0.993	0.000
B08.4 Enteroviral vesicular stomatitis with exanthem	0.007	0.993	0.000
B08.3 Erythema infectiosum [fifth disease]	0.007	0.993	0.000
B08.2 Exanthema subitum [sixth disease]	0.007	0.993	0.000
B08.0 Other orthopoxvirus infections	0.007	0.993	0.000
B06 Rubella [German measles]	0.007	0.993	0.000
B05 Measles	0.007	0.993	0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.007	0.993	0.000
B04 Monkeypox	0.007	0.993	0.000
B03 Smallpox	0.007	0.993	0.000
T65 Toxic effect of other and unspecified substances	0.007	0.993	0.000
B01 Varicella [chickenpox]	0.006	0.993	0.000
T51.8 Other alcohols	0.006	0.994	0.000
T51.3 Fusel oil	0.006	0.994	0.000
T51.2 2-Propanol	0.006	0.994	0.000
T51.1 Methanol	0.006	0.994	0.000
T39.0 Salicylates	0.006	0.994	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.994	0.006
J38.0 Paralysis of vocal cords and larynx	0.006	0.994	0.000
T54.3 Corrosive alkalis and alklali-like substances	0.006	0.994	0.000
T54.2 Corrosive acids and acid-like substances	0.006	0.994	0.000
T54.1 Other corrosive organic compounds	0.006	0.994	0.000
T54.0 Phenol and phenol homologues	0.006	0.994	0.000
T36.0 Penicillins	0.006	0.994	0.000
B02.3 Zoster ocular disease	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.006	0.994	0.000
T62.9 Noxious substance eaten as food, unspecified	0.005	0.994	0.000
Z13.6 Special screening examination for cardiovascular disorders	0.000	0.994	0.006
T63 Toxic effect of contact with venomous animals	0.005	0.994	0.000
T62.8 Other specified noxious substances eaten as food	0.005	0.994	0.000
T62.2 Other ingested (parts of) plant(s)	0.005	0.994	0.000
T62.1 Ingested berries	0.005	0.994	0.000
T62.0 Ingested mushrooms	0.005	0.994	0.000
T45.5 Anticoagulants	0.005	0.995	0.001
T52.9 Organic solvent, unspecified	0.005	0.995	0.000
T52.8 Other organic solvents	0.005	0.995	0.000
T52.4 Ketones	0.005	0.995	0.000
T52.3 Glycols	0.005	0.995	0.000
T52.2 Homologues of benzene	0.005	0.995	0.000
T52.1 Benzene	0.005	0.995	0.000
T52.0 Petroleum products	0.005	0.995	0.000
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.005	0.995	0.000
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.005	0.995	0.000
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.005	0.995	0.000
T53.5 Chlorofluorocarbons	0.005	0.995	0.000
T53.4 Dichloromethane	0.005	0.995	0.000
T53.3 Tetrachloroethylene	0.005	0.995	0.000
T53.2 Trichloroethylene	0.005	0.995	0.000
T53.1 Chloroform	0.005	0.995	0.000
T53.0 Carbon tetrachloride	0.005	0.995	0.000
T57.9 Inorganic substance, unspecified	0.005	0.995	0.000
T57.8 Other specified inorganic substances	0.005	0.995	0.000
T57.3 Hydrogen cyanide	0.005	0.995	0.000
T57.2 Manganese and its compounds	0.005	0.995	0.000
T57.1 Phosphorus and its compounds	0.005	0.995	0.000
T57.0 Arsenic and its compounds	0.005	0.995	0.000
T60.9 Pesticide, unspecified	0.005	0.995	0.000
T60.8 Other pesticides	0.005	0.995	0.000
T60.4 Rodenticides	0.005	0.995	0.000
T60.3 Herbicides and fungicides	0.005	0.995	0.000
T60.2 Other insecticides	0.005	0.995	0.000
T60.1 Halogenated insecticides	0.005	0.995	0.000
T60.0 Organophosphate and carbamate insecticides	0.005	0.995	0.000
T61.9 Toxic effect of unspecified seafood	0.005	0.995	0.000
T61.8 Toxic effect of other seafoods	0.005	0.995	0.000
T61.2 Other fish and shellfish poisoning	0.005	0.995	0.000
T61.1 Scombroid fish poisoning	0.005	0.995	0.000
T61.0 Ciguatera fish poisoning	0.005	0.995	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
B05.9 Measles without complication	0.005	0.995	0.000
B05.8 Measles with other complications	0.005	0.995	0.000
B05.4 Measles with intestinal complications	0.005	0.995	0.000
B05.3 Measles complicated by otitis media	0.005	0.995	0.000
B05.2 Measles complicated by pneumonia	0.005	0.995	0.000
B05.1 Measles complicated by meningitis	0.005	0.995	0.000
B05.0 Measles complicated by encephalitis	0.005	0.995	0.000
B06.9 Rubella without complication	0.005	0.995	0.000
B06.8 Rubella with other complications	0.005	0.995	0.000
B06.0 Rubella with neurological complications	0.005	0.995	0.000
T65.8 Toxic effect of other specified substances	0.005	0.995	0.000
T65.6 Paints and dyes, not elsewhere classified	0.005	0.995	0.000
T65.5 Nitroglycerin and other nitric acids and esters	0.005	0.995	0.000
T65.4 Carbon disulphide	0.005	0.995	0.000
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.005	0.995	0.000
T65.2 Tobacco and nicotine	0.005	0.995	0.000
T65.1 Strychnine and its salts	0.005	0.995	0.000
T65.0 Cyanides	0.005	0.995	0.000
B01.8 Varicella with other complications	0.005	0.995	0.000
B01.2 Varicella pneumonia	0.005	0.995	0.000
B01.1 Varicella encephalitis	0.005	0.995	0.000
B01.0 Varicella meningitis	0.005	0.995	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.005	0.995	0.000
B01.9 Varicella without complications	0.005	0.995	0.000
D68.9 Coagulation defect, unspecified	0.005	0.995	0.000
H11 Other disorders of conjunctiva	0.005	0.995	0.000
T65.9 Toxic effect of unspecified substance	0.004	0.995	0.000
H11.3 Conjunctival haemorrhage	0.005	0.995	0.000
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
H11.8 Other specified disorders of conjunctiva	0.004	0.996	0.000
F60.9 Personality disorder, unspecified	0.004	0.996	0.000
R59.0 Localised enlarged lymph nodes	0.004	0.996	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.996	0.004
T63.9 Toxic effect of contact with unspecified venomous animal	0.004	0.996	0.000
T63.8 Toxic effect of contact with other venomous animals	0.004	0.996	0.000
T63.6 Toxic effect of contact with other marine animals	0.004	0.996	0.000
T63.5 Toxic effect of contact with fish	0.004	0.996	0.000
T63.3 Venom of spider	0.004	0.996	0.000
T63.2 Venom of scorpion	0.004	0.996	0.000
T63.1 Venom of other reptiles	0.004	0.996	0.000
T63.0 Snake venom	0.004	0.996	0.000
M67.8 Other specified disorders of synovium and tendon	0.000	0.996	0.004
S52.0 Fracture of upper end of ulna	0.000	0.996	0.004
G12.2 Motor neuron disease	0.004	0.996	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.004	0.996	0.000
T51.9 Alcohol, unspecified	0.004	0.996	0.000
H11.1 Conjunctival degenerations and deposits	0.004	0.996	0.000
H11.2 Conjunctival scars	0.004	0.996	0.000
F31.9 Bipolar affective disorder, unspecified	0.004	0.996	0.000
K70.3 Alcoholic cirrhosis of liver	0.000	0.996	0.004
H49.0 Third [oculomotor] nerve palsy	0.004	0.996	0.000
B00 Herpesviral [herpes simplex] infections	0.003	0.996	0.000
H11.9 Disorder of conjunctiva, unspecified	0.003	0.996	0.000
H11.0 Pterygium	0.003	0.997	0.000
X41.9 Unspecified place	0.003	0.997	0.000
G12 Spinal muscular atrophy and related syndromes	0.003	0.997	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.997	0.003
M25.76 Osteophyte (Lower leg)	0.003	0.997	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.997	0.003
B00.8 Other forms of herpesviral infection	0.003	0.997	0.000
S29.9 Unspecified injury of thorax	0.003	0.997	0.000
K70.4 Alcoholic hepatic failure	0.000	0.997	0.003
G71.0 Muscular dystrophy	0.000	0.997	0.003
S52.01 Fracture of upper end of ulna (open)	0.000	0.997	0.003
I27.0 Primary pulmonary hypertension	0.003	0.997	0.000
B00.0 Eczema herpeticum	0.003	0.997	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.997	0.003
B00.7 Disseminated herpesviral disease	0.002	0.997	0.000
B00.3 Herpesviral meningitis	0.002	0.997	0.000
G71.1 Myotonic disorders	0.000	0.997	0.003
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
R00.2 Palpitations	0.003	0.997	0.000
X49.9 Unspecified place	0.003	0.997	0.000
R16.1 Splenomegaly, not elsewhere classified	0.003	0.997	0.000
R73.9 Hyperglycaemia, unspecified	0.003	0.997	0.000
F60 Specific personality disorders	0.003	0.997	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.003	0.997	0.000
F60.3 Emotionally unstable personality disorder	0.003	0.997	0.000
G12.9 Spinal muscular atrophy, unspecified	0.002	0.997	0.000
G12.8 Other spinal muscular atrophies and related syndromes	0.002	0.997	0.000
G12.1 Other inherited spinal muscular atrophy	0.002	0.997	0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.002	0.997	0.000
G14 Postpolio syndrome	0.003	0.997	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.003	0.997	0.000
T63.4 Venom of other arthropods	0.002	0.997	0.000
K70 Alcoholic liver disease	0.000	0.997	0.003
B00.4 Herpesviral encephalitis	0.002	0.997	0.000
H49 Paralytic strabismus	0.003	0.997	0.000
G11 Hereditary ataxia	0.003	0.997	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.997	0.002
H49.8 Other paralytic strabismus	0.002	0.997	0.000
E11.2 With renal complications	0.000	0.997	0.002
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
I27.8 Other specified pulmonary heart diseases	0.002	0.998	0.000
B00.9 Herpesviral infection, unspecified	0.002	0.998	0.000
Z13.5 Special screening examination for eye and ear disorders	0.000	0.998	0.002
H10-H13 Disorders of conjunctiva	0.002	0.998	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.998	0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.002	0.998	0.000
G11.1 Early-onset cerebellar ataxia	0.002	0.998	0.000
X69.0 Home	0.002	0.998	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.002	0.998	0.000
Q60.0 Renal agenesis, unilateral	0.002	0.998	0.000
B00.5 Herpesviral ocular disease	0.002	0.998	0.000
H10 Conjunctivitis	0.002	0.998	0.000
X41.0 Home	0.002	0.998	0.000
X41.8 Other specified place	0.002	0.998	0.000
X41.7 Farm	0.002	0.998	0.000
X41.6 Industrial and construction area	0.002	0.998	0.000
X41.5 Trade and service area	0.002	0.998	0.000
X41.4 Street and highway	0.002	0.998	0.000
X41.3 Sports and athletics area	0.002	0.998	0.000
X41.2 School, other institution and public administrative area	0.002	0.998	0.000
X41.1 Residential institution	0.002	0.998	0.000
F60.0 Paranoid personality disorder	0.002	0.998	0.000
X47.0 Home	0.002	0.998	0.000
F60.8 Other specific personality disorders	0.002	0.998	0.000
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease	0.002	0.998	0.000
X47 Accidental poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.002	0.998	0.000
D69.6 Thrombocytopenia, unspecified	0.000	0.998	0.002
K70.9 Alcoholic liver disease, unspecified	0.000	0.998	0.002
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.998	0.002
G71 Primary disorders of muscles	0.000	0.998	0.002
X40-X49 Accidental poisoning by and exposure to noxious substances	0.002	0.998	0.000
G11.9 Hereditary ataxia, unspecified	0.002	0.998	0.000
H18.2 Other corneal oedema	0.000	0.998	0.002
H10.4 Chronic conjunctivitis	0.002	0.998	0.000
F60.4 Histrionic personality disorder	0.002	0.998	0.000
F60.2 Dissocial personality disorder	0.002	0.998	0.000
F60.1 Schizoid personality disorder	0.002	0.998	0.000
G10 Huntington's disease	0.002	0.998	0.000
H49.4 Progressive external ophthalmoplegia	0.002	0.998	0.000
H49.9 Paralytic strabismus, unspecified	0.002	0.998	0.000
H49.1 Fourth [trochlear] nerve palsy	0.002	0.998	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.002	0.998	0.000
H49.3 Total (external) ophthalmoplegia	0.002	0.998	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.998	0.002
X49.6 Industrial and construction area	0.002	0.998	0.000
I27 Other pulmonary heart diseases	0.002	0.998	0.000
G11.8 Other hereditary ataxias	0.002	0.998	0.000
G11.3 Cerebellar ataxia with defective DNA repair	0.002	0.998	0.000
G11.2 Late-onset cerebellar ataxia	0.002	0.998	0.000
G11.0 Congenital nonprogressive ataxia	0.002	0.998	0.000
H10.1 Acute atopic conjunctivitis	0.002	0.998	0.000
Z13.3 Special screening examination for mental and behavioural disorders	0.000	0.998	0.002
G11.4 Hereditary spastic paraplegia	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
X49.4 Street and highway	0.002	0.998	0.000
X49.0 Home	0.002	0.998	0.000
X49.8 Other specified place	0.002	0.998	0.000
X49.7 Farm	0.002	0.998	0.000
X49.5 Trade and service area	0.002	0.998	0.000
X49.3 Sports and athletics area	0.002	0.998	0.000
X49.2 School, other institution and public administrative area	0.002	0.998	0.000
X49.1 Residential institution	0.002	0.998	0.000
Z13 Special screening examination for other diseases and disorders	0.000	0.998	0.002
H10.5 Blepharoconjunctivitis	0.002	0.998	0.000
Q38.7 Pharyngeal pouch	0.002	0.998	0.000
R77.9 Abnormality of plasma protein, unspecified	0.002	0.998	0.000
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere	0.002	0.998	0.000
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema	0.002	0.998	0.000
G13.0 Paraneoplastic neuromyopathy and neuropathy	0.002	0.998	0.000
H72 Perforation of tympanic membrane	0.000	0.998	0.002
Z60.2 Living alone	0.000	0.998	0.002
H49.2 Sixth [abducent] nerve palsy	0.002	0.998	0.000
H13 Disorders of conjunctiva in diseases classified elsewhere	0.002	0.998	0.000
H04.1 Other disorders of lachrymal gland	0.000	0.998	0.002
H59.0 Vitreous syndrome following cataract surgery	0.000	0.998	0.002
Q60.2 Renal agenesis, unspecified	0.002	0.998	0.000
H10.8 Other conjunctivitis	0.002	0.998	0.000
H10.3 Acute conjunctivitis, unspecified	0.002	0.998	0.000
H10.2 Other acute conjunctivitis	0.002	0.998	0.000
H10.0 Mucopurulent conjunctivitis	0.002	0.998	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.000	0.998	0.002
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
X41.08 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified , Home ,While engaged in other specified activities	0.002	0.998	0.000
H95.1 Other disorders following mastoidectomy	0.002	0.998	0.000
K70.1 Alcoholic hepatitis	0.000	0.998	0.002
X47.9 Unspecified place	0.002	0.998	0.000
O21.0 Mild hyperemesis gravidarum	0.000	0.998	0.002
X43 Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
M25.46 Effusion of joint (Lower leg)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations